vimarsana.com

Page 4 - Corneal Disease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recalled Eye Drops Lead to More Deaths, Removals of Eyes

AD Outcomes Improved With Lebrikizumab and Topical Steroids

The ADhere study compared responses at 16 weeks to the investigational biologic and topical corticosteroids vs topical corticosteroids alone in adults and adolescents with moderate to severe AD.

Diabetes Link Found for Fuchs Corneal Endothelial Dystrophy

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.